Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of PCV13 in Chronic Dialysis Patients
NCT02492438Phase 4Completed
- Sponsor
- AZ Sint-Jan Brugge
- Start
- Feb 2013
- Primary completion
- Feb 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Prevnar 13 in pneumococcal infection, sponsored by AZ Sint-Jan Brugge. Started Feb 2013; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02492438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492438.